This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Michael Hauptmann group


Michael Hauptmann

Personal details


Michael Hauptmann received a Ph.D. in Statistics from the University of Dortmund (Germany) in 1999. In the same year, he joined the Biostatistics Branch of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute in Bethesda, Maryland (USA), as a postdoctoral fellow, and became a tenure-track investigator in 2004. From 2006 to 2019, Dr. Hauptmann was a senior statistician and head of the Biostatistics group at the Netherlands Cancer Institute in Amsterdam (The Netherlands). Since 2019, Michael Hauptmann is a professor of Biostatistics and Registry Research at the Brandenburg Medical School in Neuruppin, Germany. His research interests include statistical methods for the evaluation of health effects from medical radiation exposure, design and statistical analysis of clinical studies for predictive marker evaluation, prediction of risks for cancer and cardiovascular disease among cancer survivors, and innovative design and statistical analysis of animal studies in cancer research. Dr. Hauptmann is a Statistical Editor for the Journal of the National Cancer Institute and the Journal of Clinical Oncology, and is a member of the International Commission on Radiological Protection and of the Board of Advisors of the Dutch Cancer Society.

For a complete CV, click here.

Share this page